Sina Fatehi,Matthew J Rok,Ryan M Marks,Emily Huynh,Natalie Kozman,Hong Anh Truong,Lijun Chi,Bei Yan,Enzhe Khazeeva,Paul Delgado-Olguin,Evgueni A Ivakine,Ronald D Cohn
{"title":"Template-assisted sequence knock-in rescues skeletal and cardiac muscle function in a deletion model of Duchenne muscular dystrophy.","authors":"Sina Fatehi,Matthew J Rok,Ryan M Marks,Emily Huynh,Natalie Kozman,Hong Anh Truong,Lijun Chi,Bei Yan,Enzhe Khazeeva,Paul Delgado-Olguin,Evgueni A Ivakine,Ronald D Cohn","doi":"10.1016/j.ymthe.2025.05.005","DOIUrl":null,"url":null,"abstract":"Duchenne muscular dystrophy (DMD) poses challenges in therapy design due to dystrophin's complex role in maintaining muscle function since the restoration of truncated protein products has failed to completely address the disease's pathophysiology in clinical trials. As ∼70% of patients harbour deletions, strategies enabling targeted DNA insertion to restore full-length dystrophin protein are essential. Here, we present template-assisted sequence knock-in (TASK), a strategy that we employed to specifically correct the Dmd Δ52-54 mutation in a murine model. By co-delivering a repair template and the Cas9 nuclease using AAV9s, the splice-competent sequence for Dmd exons 52-54 was integrated into the residual intron 54 locus, resulting in the systemic restoration of full-length dystrophin at therapeutically relevant levels in the heart and across all skeletal muscles, leading to significant functional improvements. TASK demonstrates the highest efficiency of exogenous DNA knock-in reported to date, achieving rescue of key dystrophic hallmarks in a deletion model of DMD.","PeriodicalId":19020,"journal":{"name":"Molecular Therapy","volume":"16 1","pages":""},"PeriodicalIF":12.1000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ymthe.2025.05.005","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Duchenne muscular dystrophy (DMD) poses challenges in therapy design due to dystrophin's complex role in maintaining muscle function since the restoration of truncated protein products has failed to completely address the disease's pathophysiology in clinical trials. As ∼70% of patients harbour deletions, strategies enabling targeted DNA insertion to restore full-length dystrophin protein are essential. Here, we present template-assisted sequence knock-in (TASK), a strategy that we employed to specifically correct the Dmd Δ52-54 mutation in a murine model. By co-delivering a repair template and the Cas9 nuclease using AAV9s, the splice-competent sequence for Dmd exons 52-54 was integrated into the residual intron 54 locus, resulting in the systemic restoration of full-length dystrophin at therapeutically relevant levels in the heart and across all skeletal muscles, leading to significant functional improvements. TASK demonstrates the highest efficiency of exogenous DNA knock-in reported to date, achieving rescue of key dystrophic hallmarks in a deletion model of DMD.
期刊介绍:
Molecular Therapy is the leading journal for research in gene transfer, vector development, stem cell manipulation, and therapeutic interventions. It covers a broad spectrum of topics including genetic and acquired disease correction, vaccine development, pre-clinical validation, safety/efficacy studies, and clinical trials. With a focus on advancing genetics, medicine, and biotechnology, Molecular Therapy publishes peer-reviewed research, reviews, and commentaries to showcase the latest advancements in the field. With an impressive impact factor of 12.4 in 2022, it continues to attract top-tier contributions.